06127
- 即時昭衍新藥
- 23.440+0.960 (+4.270%)
- 營業額 / 收益
- 除稅前溢利 / (虧損)
- 股東應佔溢利 / (虧損)
- 每股盈利
- 668,575
- -21.285%
- 849,357
- 1,012,077
- 776,881
- 534,556
- (563,580)
- -11.672%
- (638,056)
- (564,278)
- (398,939)
- (265,985)
- 104,995
- -50.310%
- 211,301
- 447,799
- 377,942
- 268,571
- 94,977
- --
- (254,441)
- (198,770)
- 131,321
- 37,764
- 80,119
- --
- (177,351)
- 116,936
- 435,148
- 172,631
- (19,187)
- --
- 5,113
- (27,428)
- (64,764)
- (19,538)
- 60,932
- --
- (169,742)
- 90,627
- 371,120
- 153,735
- (40,547)
- -32.850%
- (60,383)
- (59,180)
- (66,956)
- (1,111)
- 76,519
- 26.263%
- 60,603
- 57,215
- 50,560
- 37,389
市場價值指標
- 8.000
- --
- -23.000
- 12.000
- 50.000
- 30.714
- 0.000
- --
- 0.000
- 0.000
- 0.000
- 0.000
- 10.862
- --
- 10.556
- 10.691
- 9.891
- 8.895697